Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe?-Reference-Cited by-同舟云学术

Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe?

Published:2009-01 Issue:1 Volume:84 Page:3-5
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Steensma David P.

Publisher

Wiley

Subject

Hematology

Reference33 articles.

1. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia;Bessho;Int J Cell Cloning,1990

2. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study;Stebler;Exp Hematol,1990

3. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin;Bowen;Br J Haematol,1991

4. Treatment of myelodysplastic syndromes with recombinant human erythropoietin;Hellstrom;Eur J Haematol,1991

5. Recombinant human erythropoietin in patients with myelodysplastic syndromes;Schouten;Leukemia,1991

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoiesis-stimulating agents for myelodysplastic syndromes;Cochrane Database of Systematic Reviews;2016-02-04

2. High-dose darbepoetin therapy in a diabetic kidney disease patient with myelodysplastic syndrome;Nihon Toseki Igakkai Zasshi;2015

3. Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines;Leukemia Research;2013-06

4. Historical perspectives on myelodysplastic syndromes;Leukemia Research;2012-12

5. Erythropoiesis-stimulating agents for myelodysplastic syndromes;Cochrane Database of Systematic Reviews;2012-07-11